Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
101
datasets available to search
ShareScore release 0.9.0
Dataset results
101 results for “acute GVHD”
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT06265584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant
ClinicalTrials.gov study NCT00088543. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
ClinicalTrials.gov study NCT03840512. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHD
ClinicalTrials.gov study NCT03812705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant
ClinicalTrials.gov study NCT05186857. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD
ClinicalTrials.gov study NCT02027805. IPD Sharing: Not stated. Countries: 2. Publications: 0.
FMT for Steroid Resistant Gut Acute GVHD
ClinicalTrials.gov study NCT04285424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT01596075. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)
ClinicalTrials.gov study NCT03172455. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Tran
ClinicalTrials.gov study NCT06480630. IPD Sharing: NO. Countries: 1. Publications: 0.
ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD
ClinicalTrials.gov study NCT04227938. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
ClinicalTrials.gov study NCT04314219. IPD Sharing: NO. Countries: 1. Publications: 0.
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD
ClinicalTrials.gov study NCT04269850. IPD Sharing: NO. Countries: 1. Publications: 0.
Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD
ClinicalTrials.gov study NCT05921305. IPD Sharing: NO. Countries: 1. Publications: 0.
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
ClinicalTrials.gov study NCT00603330. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD
ClinicalTrials.gov study NCT04059757. IPD Sharing: YES. Countries: 1. Publications: 0.
Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
ClinicalTrials.gov study NCT01569373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD
ClinicalTrials.gov study NCT07364617. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.
ClinicalTrials.gov study NCT05370976. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic
ClinicalTrials.gov study NCT06083129. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.